Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

3
Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar?

2018-07-19 zacks
The iShares Morningstar Large-Cap Value ETF (JKF - Free Report) was launched on 06/28/2004, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Value segment of the US equity market.
VTV IWD XOM JKF

6
Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?

2018-07-16 zacks
If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the iShares Russell Top 200 Value ETF (IWX - Free Report) , a passively managed exchange traded fund launched on 09/22/2009.
VTV GTT IWD XOM

14
This ETF Lives Up To Its Name

2018-07-12 seekingalpha
A recent look at the ETFs with more than $1 billion if inflows this year revealed that many investors are still chasing momentum.
SDY IWD GM.WS.A GM.WS.B GM.WS.C DVY GM GM.WSB

6
Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar?

2018-06-22 zacks
Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the iShares Morningstar Large-Cap Value ETF (JKF - Free Report) is a passively managed exchange traded fund launched on 06/28/2004.
VTV IWD XOM JKF

6
Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?

2018-06-19 zacks
If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the iShares Russell Top 200 Value ETF (IWX - Free Report) , a passively managed exchange traded fund launched on 09/22/2009.
VTV IWD XOM

25
Should SPDR Russell 1000 Yield Focus ETF (ONEY) Be on Your Investing Radar?

2018-05-31 zacks
Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the SPDR Russell 1000 Yield Focus ETF (ONEY - Free Report) , a passively managed exchange traded fund launched on 12/02/2015.
IMMR ALIMR TGT VTV IWD ONEY JSC JPP VLO HPQ

40
Should SPDR Portfolio S&P 500 Value ETF (SPYV) Be on Your Investing Radar?

2018-05-23 zacks
Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the SPDR Portfolio S&P 500 Value ETF (SPYV - Free Report) is a passively managed exchange traded fund launched on 09/25/2000.
BRK.A VTV IWD XOM

44
Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?

2018-05-23 zacks
The PowerShares Dividend Achievers Portfolio (PFM - Free Report) was launched on 09/15/2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Value segment of the US equity market.
VTV JNJ IWD XOM MSFT

57
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Hot ETF Right Now?

2018-05-21 zacks
Making its debut on 10/21/2015, smart beta exchange traded fund SPDR Portfolio S&P 500 High Dividend ETF (SPYD - Free Report) provides investors broad exposure to the Large Cap ETFs category of the U.S. equity market.
VTV IWD M VLO AES.PRC AES CSIQ

45
Is First Trust Rising Dividend Achievers ETF (RDVY) a Hot ETF Right Now?

2018-05-18 zacks
Launched on 01/07/2014, the First Trust Rising Dividend Achievers ETF (RDVY - Free Report) is a smart beta exchange traded fund offering broad exposure to the Large Cap ETFs category of the U.S. equity market.
VTV ADPVV IWD ADP VLO

67
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?

2018-05-16 zacks
The SPDR Portfolio S&P 500 High Dividend ETF (SPYD - Free Report) was launched on 10/21/2015, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Value segment of the US equity market.
HD VTV IWD M VLO AES.PRC AES

83
Should iShares Edge MSCI Multifactor USA ETF (LRGF) Be on Your Investing Radar?

2018-05-15 zacks
The iShares Edge MSCI Multifactor USA ETF (LRGF - Free Report) was launched on 04/28/2015, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Value segment of the US equity market.
ATHTF NOC VTV IWD ACN ANTM ANTX

8
Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar?

2018-05-07 zacks
Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the iShares Morningstar Large-Cap Value ETF (JKF - Free Report) is a passively managed exchange traded fund launched on 06/28/2004.
VTV UNP IWD XOM JKF

28
Should SPDR Russell 1000 Yield Focus ETF (ONEY) Be on Your Investing Radar?

2018-05-02 zacks
Launched on 12/02/2015, the SPDR Russell 1000 Yield Focus ETF (ONEY - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Value segment of the US equity market.
DQ TGT VTV TXN IWD ONEY JSC JPP VLO HPQ

76
Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?

2018-04-26 zacks
If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the PowerShares Dividend Achievers Portfolio (PFM - Free Report) , a passively managed exchange traded fund launched on 09/15/2005.
VTV JNJ IWD XOM MSFT ADM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to IWD / iShares Russell 1000 Value ETF on message board site Silicon Investor.

Highwood Res. Ltd (T.HWD, HIWDF)
CUSIP: 464287598